New Brunswick Scientific Names New Chief Financial Officer
11 Janeiro 2006 - 9:40AM
PR Newswire (US)
EDISON, N.J., Jan. 11 /PRNewswire-FirstCall/ -- New Brunswick
Scientific Co., Inc. (NBS) (NASDAQ:NBSC), a leading provider of a
comprehensive line of research equipment and scientific
instrumentation for use in the life science industry, today
announced that Thomas E. Bocchino, 46, has been appointed vice
president, Finance and chief financial officer, replacing Samuel
Eichenbaum who, as previously announced, will retire as an employee
of the company effective January 31, 2006. For the past five years,
Bocchino was chief financial officer of IVC Industries Inc., now a
subsidiary of Inverness Medical Innovations, Inc., with
responsibilities for financial reporting, internal control and
Sarbanes-Oxley compliance. He served as IVC's controller from 1990
to 1997. Prior to joining IVC, Bocchino gained industry experience
through increasingly responsible positions with Rheem Manufacturing
Co.'s Container Division, Jazz Photo Corp. and in public
accounting. Bocchino earned his bachelor's degree in Business
Administration from the University of Dayton. He is a Certified
Public Accountant in the State of New Jersey. Commenting on the new
hire, NBS co-founder and Chairman David Freedman stated, "We are
pleased to welcome Tom to our company and look forward to his
contribution toward achievement of our strategic objectives and the
enhancement of shareholder value. "We also would like to take this
opportunity to commend Sam Eichenbaum for his 21 years of dedicated
service to our company, and wish him much happiness in his
retirement." To be added to New Brunswick Scientific's e-mail
distribution list, please click on the link below:
http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html
About New Brunswick Scientific New Brunswick Scientific Co., Inc.,
is a leading global provider of a comprehensive line of research
equipment and scientific instrumentation for use in the life
science industry. The Company's products are used in the creation,
maintenance and control of physical and biochemical environments
required for the growth, detection and storage of microorganisms
for medical, biological and chemical applications, as well as
environmental research and commercial product development. NBS is a
forerunner in the research and development of pioneering equipment
to meet the challenges of new areas of advancement in life science.
Established in 1946, New Brunswick Scientific is headquartered in
Edison, New Jersey, with sales and distribution facilities
strategically located in the United States, Europe and Asia. For
more information, please visit http://www.nbsc.com/. This press
release contains "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements may be identified by words such as
"expects," "anticipates," "intends," "plans," "believes," "seeks,"
"estimates," "will" or words of similar meaning and include, but
are not limited to, statements about the expected future business
and financial performance of the Company. The forward-looking
statements involve a number of risks and uncertainties, including
but not limited to: changes in economic conditions, demand for the
Company's products, pricing pressures, intense competition in the
industries in which the Company operates, the need for the Company
to keep pace with technological developments and respond in a
timely manner to changes in customer needs, the Company's
dependence on third-party suppliers, the effect on foreign sales of
currency fluctuations, acceptance of new products, the labor
relations of the Company and its customers and other factors
identified in the Company's Securities and Exchange Commission
filings. Forward-looking statements are based on management's
current expectations and assumptions, which are inherently subject
to uncertainties, risks and changes in circumstances that are
difficult to predict. Actual outcomes and results may differ
materially from these expectations and assumptions due to changes
in global political, economic, business, competitive, market,
regulatory and other factors. The Company undertakes no obligation
to publicly update or review any forward-looking information,
whether as a result of new information, future developments or
otherwise. DATASOURCE: New Brunswick Scientific Co., Inc. CONTACT:
James Orcutt, President & Chief Operating Officer of New
Brunswick Scientific Co., Inc., +1-732-650-2525, ; or Matthew J.
Dennis, CFA, NBS Investor Relations of Clear Perspective Group,
LLC, for New Brunswick Scientific Co., Inc., +1-440-353-0552, Web
site: http://www.nbsc.com/
Copyright
New Brunswick Scientific (NASDAQ:NBSC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
New Brunswick Scientific (NASDAQ:NBSC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024